|
2016
|
Invention
|
Method for treating geographic atrophy associated with age-related macular degeneration.
Disclos... |
|
|
Invention
|
Pharmaceutical composition comprising fatty acid derivative.
An oral pharmaceutical composition ... |
|
|
Invention
|
Pharmaceutical compositions comprising fatty acid derivative. An oral pharmaceutical composition ... |
|
|
Invention
|
Pharmaceutical composition for use in the treatment of cancer. Provided are a method and a pharma... |
|
|
Invention
|
Anti-human vap-1 monoclonal antibody. Provided is an anti-human VAP-1 monoclonal antibody having ... |
|
|
Invention
|
Pharmaceutical composition for treating cerebral infarction. The object of the present invention ... |
|
2015
|
Invention
|
Benzene or thiophene derivative and use thereof as vap-1 inhibitor. The present invention provide... |
|
|
Invention
|
Pharmaceutical composition for treating geographic atrophy associated with age-related macular de... |
|
2014
|
Invention
|
Method for screening an agent being useful for the treatment of dry eye and/or corneal and conjun... |
|
|
Invention
|
Eye drops. 2 (“FGLM”), or a pharmaceutically acceptable salt thereof. The concentration ratio of ... |
|
|
Invention
|
Soft-gelatin capsule formulation.
The present invention discloses a soft gelatin capsule formula... |
|
|
Invention
|
Composition and method for promoting hair growth.
The present invention provides a method and co... |
|
|
Invention
|
Composition and method for scalp and hair treatment.
Provided is a composition for scalp and hai... |
|
2012
|
Invention
|
Method for preparing a fatty acid derivative. Disclosed is a method for manufacturing a fatty aci... |
|
|
Invention
|
Method for preparing a fatty acid derivative. A method for manufacturing a fatty acid derivative ... |
|
|
Invention
|
Pharmaceutical composition for inflammatory diseases, allergic diseases and autoimmune diseases. ... |
|
|
Invention
|
Liquid medicament applicator.
The present invention provides an applicator, which holds an inten... |
|
|
Invention
|
Drug solution applicator. The invention holds a prescribed amount of a drug solution and applies ... |
|
|
Invention
|
Aqueous ophthalmic composition.
Disclosed is an aqueous ophthalmic composition comprising (a) a ... |
|
|
Invention
|
Aqueous ophthalmic composition. Disclosed is an aqueous ophthalmic composition comprising (a) a f... |
|
2011
|
Invention
|
Method for diagnosing and/or evaluating retinal disease.
The present application provides a meth... |
|
|
Invention
|
Eye drop composition containing isopropyl unoprostone. An eye drop composition in which the degra... |
|
|
Invention
|
Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cycl... |
|
|
Invention
|
Method for treating macular edema.
Provided is a method for treating macular edema in a mammalia... |
|
|
Invention
|
Method for treating retinal disease.
The present application provides a method for treating a re... |
|
|
Invention
|
Pharmaceutical composition for treating macular edema. Provided is a pharmaceutical composition c... |
|
|
Invention
|
Method and ophthalmic composition for treating retinal disease. The present application provides ... |
|
2010
|
Invention
|
Method for screening drug efficacious in treating dry eye and/or keratoconjunctival disorders and... |
|
|
Invention
|
Therapeutic agent for gastrointestinal disease.
The present invention provides a therapeutic age... |
|
|
Invention
|
Eye drops. 2 (“FGLM”), or a pharmacologically acceptable salt thereof. The concentration ratio be... |
|
|
Invention
|
Composition for topical administration to eyes for use in treatment of ocular hypertension and gl... |
|
|
Invention
|
Methods for treating a skin wound. 2 (SEQ ID NO: 2) or substance P or pharmaceutically acceptable... |
|
|
Invention
|
Method for preparing prostaglandin derivative. Disclosed is a method for preparing a prostaglandi... |
|
2009
|
Invention
|
Pharmaceutical composition comprising a prostaglandin. Provided is a pharmaceutical composition c... |
|
|
Invention
|
Pharmaceutical composition.
Provided is a pharmaceutical composition comprising: a) a prostaglan... |
|
|
Invention
|
Pharmaceutical composition for the treatment of dry eye and/or corneal and conjunctival lesion.
... |
|
|
Invention
|
Pharmaceutical composition for treatment of dry eye and/or corneal/conjunctival disorders. Disclo... |
|
|
Invention
|
Thiazole derivative and use thereof as vap-1 inhibitor. 1—NH—X—Y—Z wherein each symbol is as defi... |
|
2008
|
Invention
|
Pharmaceutical composition for treatment of cataract.
The present invention aims to provide a ph... |
|
|
Invention
|
Composition for ophtalmic disease associated with hypoxia or ischemia.
According to the present ... |
|
2007
|
G/S
|
Ophthalmic pharmaceutical preparations
Chemical preparations for use in the manufacture of pharma... |
|
|
G/S
|
Chemical preparations for use in the manufacture of pharmaceutical preparations for ophthalmic, o... |
